A detailed history of Met Life Investment Management, LLC transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 12,859 shares of THRD stock, worth $173,596. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,859
Previous 11,604 10.82%
Holding current value
$173,596
Previous $109,000 53.21%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$8.74 - $15.54 $10,968 - $19,502
1,255 Added 10.82%
12,859 $167,000
Q1 2024

May 14, 2024

BUY
$8.6 - $11.24 $99,794 - $130,428
11,604 New
11,604 $109,000
Q3 2023

May 09, 2024

BUY
$4.92 - $7.09 $57,091 - $82,272
11,604 New
11,604 $74,000
Q3 2023

Apr 29, 2024

BUY
$4.92 - $7.09 $57,091 - $82,272
11,604 New
11,604 $74,000
Q3 2023

Nov 14, 2023

BUY
$4.92 - $7.09 $57,091 - $82,272
11,604 New
11,604 $74,000

Others Institutions Holding THRD

About Third Harmonic Bio, Inc.


  • Ticker THRD
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,328,900
  • Market Cap $544M
More about THRD
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.